Literature DB >> 10564235

Renal cortical ceramide patterns during ischemic and toxic injury: assessments by HPLC-mass spectrometry.

T Kalhorn1, R A Zager.   

Abstract

Ceramides are a class of signaling molecules that can acutely accumulate in tissues as part of a "stress response." They are classically measured by the diacylglycerol kinase assay, which, in general, measures total ceramide rather than individual moieties within the diverse ceramide family. The present study was undertaken to 1) adapt current HPLC-mass spectrometry technology for measuring individual renal ceramides, and 2) use this technique to more fully characterize the nature of the renal ceramide "stress" reaction. Renal cortical tissues were obtained from CD-1 mice under control conditions and 2 or 18 h after renal injury (ischemia-reperfusion and glycerol-mediated myohemoglobinuria). C24, C22, and C16 ceramides were identified in normal renal cortex, constituting 70, 10, and 20% of the total ceramide pool, respectively. Within each of these families, heterogeneity was apparent because of differing degrees of unsaturation (0-3 double bonds) in the constituent fatty acid of ceramide. Renal injury dramatically changed ceramide profiles: 1) total ceramide increased by approximately 300%; 2) although all ceramides participated in this reaction, they did so to differing degrees; 3) this caused pronounced changes in ceramide distribution patterns; 4) injury induced a striking shift toward unsaturated (vs. saturated) fatty acids within the C22 and C24 (but not the C16) ceramide pools; and 5) the extent of these qualitative changes differed according to the etiology of the initiating renal damage. Thus we conclude that ceramide stress response involves major qualitative (and not simply quantitative) changes in ceramide expression that are partially disease dependent. These findings underscore the fact that simply measuring total renal ceramide content (e.g., by diacylglycerol kinase assay) substantially oversimplifies the nature and, hence, the potential implications of the ceramide stress reaction.

Entities:  

Mesh:

Substances:

Year:  1999        PMID: 10564235     DOI: 10.1152/ajprenal.1999.277.5.F723

Source DB:  PubMed          Journal:  Am J Physiol        ISSN: 0002-9513


  7 in total

1.  Renal cholesterol accumulation: a durable response after acute and subacute renal insults.

Authors:  R A Zager; T Andoh; W M Bennett
Journal:  Am J Pathol       Date:  2001-08       Impact factor: 4.307

Review 2.  Implications of Sphingolipid Metabolites in Kidney Diseases.

Authors:  Shamroop Kumar Mallela; Sandra Merscher; Alessia Fornoni
Journal:  Int J Mol Sci       Date:  2022-04-11       Impact factor: 6.208

Review 3.  Ceramide and mitochondria in ischemia/reperfusion.

Authors:  Sergei A Novgorodov; Tatyana I Gudz
Journal:  J Cardiovasc Pharmacol       Date:  2009-03       Impact factor: 3.105

Review 4.  Podocyte pathology and nephropathy - sphingolipids in glomerular diseases.

Authors:  Sandra Merscher; Alessia Fornoni
Journal:  Front Endocrinol (Lausanne)       Date:  2014-07-30       Impact factor: 5.555

5.  Demographic and clinical variables affecting mid- to late-life trajectories of plasma ceramide and dihydroceramide species.

Authors:  Michelle M Mielke; Veera Venkata Ratnam Bandaru; Dingfen Han; Yang An; Susan M Resnick; Luigi Ferrucci; Norman J Haughey
Journal:  Aging Cell       Date:  2015-07-20       Impact factor: 9.304

Review 6.  Lipid mediators in diabetic nephropathy.

Authors:  Swayam Prakash Srivastava; Sen Shi; Daisuke Koya; Keizo Kanasaki
Journal:  Fibrogenesis Tissue Repair       Date:  2014-09-03

Review 7.  Ceramide and Ischemia/Reperfusion Injury.

Authors:  Xingxuan He; Edward H Schuchman
Journal:  J Lipids       Date:  2018-01-21
  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.